Abstract
Comparative data on the dissolution kinetics profiles of more than 200 drug pairs have been analyzed. It is shown that the comparative dissolution test provides effective evaluation of the pharmacological equivalence during preclinical trials of generic drugs and the drugs with claimed changes in composition in the registration stage.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have